直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Wyeth v. Mylan Pharmaceuticals, Inc.

Wyeth

Mylan Pharmaceuticals, Inc.

Represented Wyeth in multiple separate Hatch-Waxman litigations concerning Effexor XR®, a multibillion dollar antidepressant; the cases were resolved through confidential settlement at various stages of litigation, including in the midst of trial.

Wyeth v. Mylan Pharmaceuticals, Inc., 1:07-cv-00091, N.D.W. Va., Judges Keeley, Kaull

Related Practices

Global IP Enforcement, Litigation, and Trials

Pretrial Strategies

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Wyeth v. Lupin Ltd and Lupin Pharmaceuticals, Inc.

Wyeth

AbbVie Inc. v. Mylan Laboratories, Inc.

AbbVie Inc.

Wyeth v. Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc.

Wyeth

Wyeth v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.

Wyeth

Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc. 

Valeant; Salix; Progenics

Wyeth v. Sandoz, Inc.

Wyeth

Wyeth v. Osmotica Pharmaceutical Corp.

Wyeth

Wyeth v. Anchen Pharmaceuticals, Inc.

Wyeth

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. 

Abbott Laboratories

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP